K082047 · Interrad Medical, Inc. · OKC · Sep 30, 2008 · General Hospital
Device Facts
Record ID
K082047
Device Name
SECURACATH CATHETER, MODEL SPK01
Applicant
Interrad Medical, Inc.
Product Code
OKC · General Hospital
Decision Date
Sep 30, 2008
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 880.5970
Device Class
Class 2
Intended Use
The SecurAcath is a PICC and is indicated for short and long term use in peripheral vessels to access the central venous system. The catheter may be used for blood sampling and/or infusion therapy. The SecurAcath PICC includes means to secure the catheter via a subcutaneous anchor below the insertion site.
Device Story
SecurAcath is a single-use, sterile, flexible dual-lumen PICC (up to 60 cm length) with integrated subcutaneous securement mechanism; designed for peripheral vessel insertion to access central venous system. Device features 1 cm markings for trimming; compatible with 0.018" or smaller guidewires. Securement mechanism located in Y-body stabilizes catheter below insertion site. Used by clinicians for infusion therapy and blood sampling. Benefits include catheter stabilization to prevent migration. Performance verified via bench testing including dimensional verification, securement reliability, and tensile strength.
Clinical Evidence
Bench testing only. Testing included dimensional verification, securement reliability, and catheter tensile strength. No clinical data presented.
Technological Characteristics
Flexible dual-lumen PICC catheter; up to 60 cm length; integrated subcutaneous securement mechanism in Y-body; compatible with 0.018" guidewires; sterile, single-use.
Indications for Use
Indicated for short and long-term peripheral vessel access to the central venous system for blood sampling and/or infusion therapy in patients requiring PICC placement.
Regulatory Classification
Identification
A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.
Special Controls
*Classification.* Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”
K091261 — NMI PICC · Navilyst Medical, Inc. · May 12, 2009
K964447 — PICC CATHETER/MIDLINE CATHETER · Menlo Care, Inc. · Apr 16, 1997
K030270 — 3F X 60 CM SINGLE LUMEN SILISONE VASCU-PICC, 4F X 60CM SINGLE LUMEN SILICONE VASCU-PICC, 5F X 60 CM SINGLE LUMEN SILICON · Medcomp · Apr 11, 2003
Submission Summary (Full Text)
{0}------------------------------------------------
K082047
SEP 3 0 2008
#### 510(K) SUMMARY 1.
#### 1.1 ADMINISTRATIVE INFORMATION
## 1.1.1 Name and address
Sponsor: Interrad Medical, Inc. 181 Cheshire Lane, Suite 100 Plymouth, MN 55441 Tel: 763-225-6699 Fax: 763-225-6695
Contact Person Sew-Wah Tay, PhD Regulatory Consultant 18555 37th Ave N, Plymouth, MN 55446
Tel: 612-801-6782 Fax: 763-208-4465 Email: swtay(@)libramed.com
Date Prepared: July 15 2008
### 1.1.2 Device Name
| Trade Name | SecurAcath Catheter |
|---------------------|-----------------------------------------------|
| Common Name | Periphery Inserted Central Catheter<br>(PICC) |
| Classification Name | Implanted subcutaneous securement<br>catheter |
| Product Code | OKC |
| Classification | 21 CFR 880.5970<br>Class II |
| Model | SPK01 |
| 1.1.3 Applicant | |
Applicant's Name: Interrad Mcdical, Inc. 181 Cheshire Lane, Suite 100 Plymouth, MN 55441 Tel: 763-225-6699 Fax: 763-225-6695
{1}------------------------------------------------
# K082047
#### 1.2 Indication for use
The SecurAcath is a PICC and is indicated for short and long term use in peripheral vessels to access the central venous system. The catheter may be used for blood sampling and/or infusion therapy. The SecurAcath PICC includes means to secure the catheter via a subcutaneous anchor below the insertion site.
#### 1.3 DEVICE DESCRIPTION
The SecurAcath is a single use, sterile, flexible PICC catheter with a useful lengths of up to 60 cm. The length of the catheter has markings at 1 cm interval to allow the user to trim the catheter to the required length. The catheter has a built in subcutaneous securement mechanism to stabilize and keep the catheter in place. The catheter has two lumens which are identical in properties and characteristics.
The device is compatible with all 0.018" and smaller guidewires. The proximal end of the catheter has the standard radiology PICC configuration plus the activation mechanism of the securement system built into the Y-body.
#### 1.4 SUBSTANTIAL EQUIVALENCE
The SccurAcath Catheter device covered by this submission is substantially equivalent to other legally marketed devices namely, the Poly-Per-Q (K0001901) Angio Dynamic Morpheus PICC (K060887), Cook Tubo0Flo (K041849), Bard Power PICC (K053501) and the Statlock CV (K943147).
The SecurAcath™ has the same general indication for use, similar principles of opcration, and similar technological characteristics as the previously cleared predicate devices. The differences between this device and its predicate devices do not raise new questions of safety or efficacy.
#### 1.5 Performance Data
The performance test data is provided in the 510(k) submission. The performance data demonstrates that the device meets all the product specifications. Performance testing included dimensional verification; securement reliability, catheter tensile strength. Test results demonstrate that the device is safe and effective for its intended use.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus, which is a symbol of medicine, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" arranged in a circular fashion around the symbol. The caduceus is depicted with three curved lines representing the snakes intertwined around a staff, which is a common representation of the symbol.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 3 0 2008
Interrad Medical, Incorporated C/O Dr. Sew-Wah Tay Regulatory Consultant Libra Medical, LLC 18555 37th Avenue North Plymouth, Minnesota 55446
Re: K082047
Trade/Device Name: SecurAcath 5F Dual Lumen PICC 65cm with Subcutancous Securement System Regulation Number: 21 CFR 880.5970 Regulation Name: Percutaneous, Implanted, Long-Term Intravascular Catheter Regulatory Class: II Product Code: OKC Dated: July 17, 2008 Reccived: July 18, 2008
Dear Dr. Tay:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Dr. Tay
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
SECTION 4.
## INDICATION FOR USE STATEMENT
510(k) Number (if known): *082047
Device Name: SecurAcath Indications for Use:
The SecurAcath is a PICC and is indicated for short and long term use in peripheral vessels to access the central venous system. The catheter may be used for blood sampling and/or infusion therapy. The SecurAcath PICC includes means to secure the catheter via a subcutaneous anchor below the insertion site.
Prescription Use _____________________________________________________________________________________________________________________________________________________________ Over-The-Counter Use _ X AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Cinton Q. Rose
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
K482047 510(k) Number:
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.